Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Armodafinil
Therapeutic Area : Sleep
Study Phase : Undisclosed
Sponsor : Teva Pharmaceutical Industries
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
September 17, 2015
Lead Product(s) : Armodafinil
Therapeutic Area : Sleep
Highest Development Status : Undisclosed
Sponsor : Teva Pharmaceutical Industries
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Armodafinil
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase II
Sponsor : Teva Pharmaceutical Industries
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 11, 2013
Lead Product(s) : Armodafinil
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase II
Sponsor : Teva Pharmaceutical Industries
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Armodafinil
Therapeutic Area : Sleep
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 20, 2012
Lead Product(s) : Armodafinil
Therapeutic Area : Sleep
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Armodafinil
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Phase IV
Sponsor : Teva Pharmaceutical Industries
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
October 27, 2011
Lead Product(s) : Armodafinil
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase IV
Sponsor : Teva Pharmaceutical Industries
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Armodafinil
Therapeutic Area : Oncology
Study Phase : Phase II
Sponsor : CEPHALON INC
Deal Size : Inapplicable
Deal Type : Inapplicable
Nuvigil or Placebo in Newly Diagnosed Malignant Glioma
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 25, 2011
Lead Product(s) : Armodafinil
Therapeutic Area : Oncology
Highest Development Status : Phase II
Sponsor : CEPHALON INC
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Armodafinil
Therapeutic Area : Psychiatry/Psychology
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
February 28, 2011
Lead Product(s) : Armodafinil
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Armodafinil
Therapeutic Area : Neurology
Study Phase : Undisclosed
Sponsor : CEPHALON INC
Deal Size : Inapplicable
Deal Type : Inapplicable
Attention Modulation for Treatment of Parkinson's Disease and Dementia With Lewy Bodies
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 09, 2010
Lead Product(s) : Armodafinil
Therapeutic Area : Neurology
Highest Development Status : Undisclosed
Sponsor : CEPHALON INC
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Armodafinil
Therapeutic Area : Oncology
Study Phase : Undisclosed
Sponsor : CEPHALON INC
Deal Size : Inapplicable
Deal Type : Inapplicable
Nuvigil in Treatment of Cancer-Related Fatigue in Chronic Myeloid Leukemia Patients
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 26, 2010
Lead Product(s) : Armodafinil
Therapeutic Area : Oncology
Highest Development Status : Undisclosed
Sponsor : CEPHALON INC
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Armodafinil
Therapeutic Area : Musculoskeletal
Study Phase : Phase III
Sponsor : CEPHALON INC
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 12, 2010
Lead Product(s) : Armodafinil
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase III
Sponsor : CEPHALON INC
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Armodafinil
Therapeutic Area : Psychiatry/Psychology
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 12, 2010
Lead Product(s) : Armodafinil
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable